Wayzata, MN (PRWEB) June 7, 2006

CO2 Partners, LLC, an organizational leadership consulting business, in partnership with The Business Development Group, has released a free briefing for businesses and organization to become better informed about the Avian Flu and how they can prepare themselves.

“Flu pandemics are like earthquakes, hurricanes, and tsunamis, they occur. There’s going to be another one. There have been ten in the last 300 years. It’s important to understand that when you’re preparing for pandemic influenza, you’re preparing for something that will happen….(H5N1) is the most powerful influenza virus we’ve seen in modern human history.” –Dr. Michael Osterholm

Dr. Osterholm is director of the Center for Infectious Disease Research and Policy (CIDRAP), associate director of the Department of Homeland Security’s National Center for Food Protection and Defense (NCFPD), and professor in the School of Public Health, University of Minnesota. He is also a member of the Institute of Medicine (IOM) of the National Academy of Sciences. In June 2005 Dr. Osterholm was appointed by Michael Leavitt, Secretary of the Department of Health and Human Services (HHS), to the newly established National Science Advisory Board on Biosecurity.

It is estimated that only 18% of all U.S. companies have any plans in place to meet the issues of an outbreak of the Avian Flu as it relates to a human pandemic influenza or fear of a pandemic. If the Avian Flu gets to the U.S. it may well have only a minor impact to the stakeholders. If however, it mutates into a human pandemic influenza, the economy could easily become paralyzed. People would isolate themselves in their homes, thus stop going to work, school and public venues. Unemployment insurance and government support services would be difficult if not impossible to access. As time continued banking, food supplies, the Internet and phone services would become disrupted. It is estimated a pandemic could cause up to 30% of all small businesses to go into bankruptcy. Referring back to the nightmare results of Katrina, as an example, it is easy to predict that the number could easily go higher.

An AI outbreak in the U.S. will have little impact on most individuals. In contrast, however, a human epidemic in the U.S. or even overseas would impact a greater number and create fear and disruptions on a global basis. A pandemic could be biblical in global devastation. It would impact the U.S. military, police and other security aspects of daily life. Few if anyone would not be touched by death and sickness.

·    57% of Americans reported concern about the spread of Avian Flu.

·    15% said they were very concerned

·    20% believe they or a relative will get the Avian Flu.

·    75% said they would avoid travel.

·    71% said they would avoid public events

Current government recommendations for families and business suggest the stockpile of critical supplies before a human pandemic occurs. It is estimated that these supplies should last from 3 weeks to 3 months and depend on the impact to the logistics of a community. Companies should create work at home plans and provide key employees with “Flu Kits” as preparation for the contingency that the virus migrates into a human transmittable strain. A pandemic event could last 12 to 18 months.

At the time of this writing, no human AI-related pandemic virus has been identified. The U.S. food supply remains safe and world health agencies are working to control this aggressive bird-related disease that has been in existence for centuries if not longer. But that could all change if this virus mutates. And many elite scientists believe it’s not just a matter of if, but when.

Peter Lytle’s “Avian Influenza and Human Pandemic Influenza Briefing” is a terrific first step toward preparing yourself and your organization for an outbreak of Avian Flu. In this educational presentation, you will be given:

·    A clear, simple primer about the Avian Flu (AI), its impact on animal populations, and the potential impact on humans

·    A government/industry report card on preparedness—both for controlling AI in poultry and a potential human pandemic

To learn more about how to obtain this free 87 page PowerPoint brief and reference sources for statistical information visit us at http://www.co2partners.com/letter.htm and please send others to our site to benefit from this critical information.

Family and individual plans are available from the CDC and can be accessed on their website: http://www.pandemicflu.gov/.

Other planning support can be accessed through The Center for Infectious Disease, Research & Policy (CIDRAP) http://www.cidrap.umn.edu/.

# # #

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

More Influenza Press Releases

Boston (PRWEB) December 6, 2007

A gene related to rapid replication and lethality has been found to be present in, and to contain some identical protein sequences in, tobacco mosaic virus and non-small cell lung cancer. The early detection diagnostic test for cancer, the AMAS® test, appears to measure this gene’s activity.

This is the first of a series of reports on the use of a new methodology to isolate ‘in silico’ and track specific gene activity in normal and several disease states.

This newly identified gene has been named the Replikin Peak Gene (RPG). “Replikins”TM are a class of proteins containing high concentrations of amino acids lysine and histidine that have been previously determined to be related to rapid replication and virulence. Using proprietary computer algorithms constructed to identify, count and track historically this class of proteins, replikins have now been analyzed in 130,488 protein and genome sequences. These include all the accession numbers for common strains of influenza and other lethal virus isolations published between 1917 and 2007 in the PubMed repository. Replikins have been found to be concentrated in specific genomic areas. The area of each genome with the highest concentration of continuous replikin peptides has been isolated in silico and named a Replikin Peak Gene (RPG).

Specific RPGs have been identified and quantified in infectious organisms including viruses, bacteria and trypanosomes (malaria). ‘Upregulation’ of the Replikin Peak Gene is evidenced by an increase in the replikin count in the RPG, that is, in the number of replikins per 100 amino acids. For example, in the case of influenza B, which has not to date been lethal, a low replikin count (less than 4) always occurred in influenza B RPGs between 1940 and 2006; and in quiescent periods of influenza A. In contrast, the replikin counts in lethal influenza A virus RPGs increased to over 20, from as much as one to three years before and during outbreaks. Strain-specific increases in replikin count have appeared in relation to the major influenza pandemics and epidemics, after years of constant low stable counts. Furthermore, a high replikin count of the RPG of an organism has been shown to be associated consistently with a higher percent lethality in the host. The increase in count was frequently detected one year or more before the outbreak was clinically apparent. The ability to identify, count and track replikins in the genomic structure of an emerging organism has been shown to be accurately predictive in advance warning of H5N1 outbreaks, and may have value in the management of influenza epidemics.

The highest replikin count of the RPG found in any organism studied to date is in lethal non-small cell lung cancer. The highest AMAS test results found to date also are in lung cancer. Tobacco mosaic virus has some sequences in its RPG that are identical to those in the RPG in non-small cell carcinoma of the lung. Two structural studies have suggested mobility and inter-organism transfer of replikins associated with lethality.

Replikins have been chemically synthesized and were found experimentally to be immunostimulants, producing strong antibody responses in animals. Synthetic cancer replikins administered to animals produce antibodies that can be measured by the AMAS cancer test. The AMAS test’s results are evidently related to the rate of replication in the cancer. In short, the AMAS test measures the activity of the replikins that are unique to cancers, whose concentration is related to lethality.

High replikin counts are present in a wide range of lethal diseases. The structural and functional relationship found between the replikin peak genes of the tobacco mosaic virus and non-small cell lung cancer is one illustration of the relationship between replikin count, rapid replication and virulence. Possible implications of these findings of the same replikin structures and functions in tobacco mosaic virus and lung cancer are under further study.

Detailed data on these studies are the subject of issued and pending published patents and are being presented today at a seminar in New York by Samuel Bogoch, M.D., Ph.D.

FluForecast® and ReplikinForecastTM are products of Replikins,LLC. The AMAS test is a product of Oncolab, Inc.

http://www.oncolabinc.com

# # #

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Orangeburg, NY (PRWEB) June 17, 2009

In response to the growing numbers of confirmed cases of H1N1 influenza A virus infection across the globe, the World Health Organization (WHO) recently declared a pandemic, the first global epidemic in 41 years. Professional Disposables International, Inc. (PDI), (http://www.pdipdi.com) a leader in infection prevention in healthcare settings, issued a reminder about the importance of hand hygiene as an effective way to stem the spread of disease.

“We are closely monitoring the latest updates from both the CDC, as well as the World Health Organization, to ensure the public is provided with the most up-to-date information available,” said Zachary T. Julius, CEO, PDI. “According to the CDC, hand hygiene remains the first step in infection prevention and it is a step each one of us can take.” H1N1 flu is highly contagious and can easily be transmitted before a person shows symptoms.

Infection Prevention Recommendations

Proper hand hygiene is the single most important means for preventing the spread of infection in schools, offices and healthcare facilities. Frequently wash hands with soap and water for 15-20 seconds. When soap and water are not available, use alcohol-based disposable hand wipes or gel sanitizers.

In healthcare settings, disinfecting hard surfaces is also critical to preventing the spread of infection between patients and healthcare workers. Avoid touching community surfaces where the virus can live for up to 2-8 hours outside the body.

Additional Resources Available for Healthcare Facilities

PDI maintains a complete portfolio of infection prevention solutions to meet the ever evolving clinical needs of the healthcare industry. The Environmental Protection Agency’s (EPA) most recent guidance for the use of antimicrobial products registered for use against influenza A viruses on hard surfaces states that any EPA accepted product with an efficacy claim against influenza A virus is also effective against H1N1 influenza virus. All three PDI Sani-Cloth® disinfecting products have claims against influenza A virus. (Please see information below regarding new EPA guidelines.)

In addition to providing efficacious disinfectants and hand hygiene products, PDI has released new protocols for both environmental surface disinfection and hand hygiene to reflect the latest guidance from the CDC and WHO.

“PDI is ready to assist our customers in responding to this growing public health threat by providing infection prevention resources, such as product usage templates updated with the latest guidance from the CDC and WHO, as well as consultations with one of our infection preventionists”, said J. Hudson Garrett Jr., Ph.D., Director of Clinical Affairs.

For additional specific guidance on infection prevention strategies specific to H1N1 influenza, please visit the CDC’s dedicated resource page at http://www.cdc.gov/h1n1flu/ or the Association for Professionals in Infection Control and Epidemiology resource page at http://www.apic.org.

For more than 30 years, PDI has pioneered the development, testing, manufacturing and marketing of pre-moistened wipes as the optimum delivery system for skin antisepsis, hand hygiene, patient and surface care. With trusted brands including Sani-Cloth®, Sani-Hands® ALC, Sani-Hands® for Kids, Hygea® and Chlorascrub™, PDI serves the healthcare market through hospitals, physician and dental offices, emergency medical services, long-term care, schools and a variety of other healthcare facilities. Professional Disposables International, Inc. is headquartered in Orangeburg, New York. For more information, visit http://www.pdipdi.com.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Cambridge, MA (PRWEB) June 23, 2009

Bio Economic Research Associates, or bio-era (http://www.bio-era.net), a leading independent research and advisory firm providing analysis on the future of the global bio economy, today announced the launch of a multi-client service to track the potential impacts of H1N1 pandemic influenza for service participants, markets and industries.

The service will provide independent, expert research and analysis on the on-going crisis, and the possible financial and business implications of the H1N1 influenza pandemic – both generally, and for the specific interests and markets of participating clients.

The service will provide:

Independent, expert analysis integrating the latest developments on the evolution of the disese event, public, media, and government perceptions of the degree of threat posed by the disease, and the reactions and responses – and the associated economic and business impacts
Scenarios for the evolution of pandemic influenza and the key implications for participating businesses, market participants, and investors.
Regular teleconferences with bio-era experts and participants to present and discuss the latest developments and bio-era analysis.
Occasional roundtables to share best practices
Under the leadership and direction of bio-era President, Stephen Aldrich, the service will deliver a steady stream of bio-era research and analysis from a distinguished expert faculty, as well as highly plausible scenarios for the evolution of the novel H1N1 pandemic, how government and public health agencies and institutions are responding, the implications for service participants – and how they can adapt.

Participants are expected to include companies with significant market exposure to trade and economic disruptions, investors, public health officials, researchers and analysts engaged in business planning, risk management, market analysis, and trading.

Novel H1N1 and the Risks of a Global Pandemic:

Now that the World Health Organization has declared the outbreak of novel variant H1N1 “swine” influenza to be a pandemic, the issue is “so what?” How will the spread of this pandemic influenza affect human societies and economies — even specific markets, industries, and companies?

We know from past experience with SARS and H5N1, and from many studies carried out over the past few years (see attached bio-era Senate Testimony), that pandemic influenza can have enormous consequences for global trade and travel, with extremely large economic impacts. Precisely because this is so, a systematic approach to developing an “early warning” system with respect to the evolution of the disease event – its current and future trajectory, the local and global implications, and the reactions these provoke – can provide enormous benefits and opportunities to those prepared to act.

Learning What to Watch

This service is designed to help stakeholders address the following questions:

What indicators should the business community be watching with respect to the unfolding H1N1 pandemic?
What specific actions (travel advisories, quarantines, travel restrictions, etc.) are governments and public health authorities initiating, and what should we expect going forward?
How are local outbreaks of novel H1N1 changing perceptions and the degree of fear generally? How are perceptions and fears driving the response to the disease?
How and when will fears and the responses they provoke impact regional and global economies and the businesses operating within and/or interconnected with these regions?
How should businesses and market participants adapt?
By delivering a scenarios framework and logic to bound plausible outcomes, and providing continuous, expert evaluation of new developments in a manner which directly relates back to the scenarios framework – referencing key signposts, and signaling important forks in the road — the service aims to improve commercial and business decision-making ahead of time – particularly in an environment likely to see a heightening of conflicting information, rumor, and fear.

To enroll in the service, or for more information, please visit http://www.bio-era.net or contact Stephen Aldrich or Grant Hastings at 617 876-2400.

###

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Orangeburg, NY (PRWEB) August 22, 2009

Growing apprehension around the upcoming flu season has led to infection prevention being a prime topic during the 2009 HIDA MedSurg Conference & Expo™, September 9-11 in Washington, D.C. Professional Disposables International, Inc. (http://www.pdipdi.com), the global leader in wet wipe infection prevention, education and patient care, will place 16 hand-sanitizing stations throughout the conference near eating areas and restrooms in their role as official hand sanitizer provider.

“Especially in the midst of the influenza season, educating distributor partners on the importance of an effective hand hygiene program is of vital importance,” said Joann Reilly, PDI Senior Director of Marketing. “This way they can help their customers towards achieving the goal of zero Healthcare Acquired Infections (HAI).”

Hand hygiene is one of the most significant interventions to decrease the risk for transmission of the novel H1N1 (swine flu) virus. When soap and water are not available, alcohol-based disposable hand wipes or gel sanitizers may be used.(1)

Recently, PDI partnered with the Association for Professionals in Infection Control and Epidemiology, Inc. (APIC), and the Safe Care Campaign, a patient advocacy group, to create a comprehensive toolkit for healthcare staff on infection prevention techniques. Samples of “The Champion’s Kit” will be available at PDI’s booth #1016.

PDI is committed to infection prevention in all areas of the healthcare industry as the resource for education and sanitation and disinfection products. PDI® Super Sani-Cloth® Germicidal Disposable Cloth and Sani-Cloth® Plus Germicidal Disposable Cloth are registered by the EPA as effective against Influenza A viruses when used as directed. The individual claims are listed below(2):

Super Sani-Cloth® Germicidal Disposable Cloth: Influenza A2/Hong Kong and Influenza A (H1N1) Virus/Strain A/Malaya/302/54
Sani-Cloth® Plus Germicidal Disposable Cloth: Influenza A2/Hong Kong

For over 30 years, PDI has pioneered the development, testing, manufacturing and marketing of pre-moistened wipes as the optimum delivery system for skin antisepsis, hand hygiene, patient and surface disinfection. With trusted brands including Sani-Cloth®, Sani-Hands® ALC, Sani-Hands® for Kids, Hygea® and Chlorascrub™, PDI serves the healthcare market through hospitals, physician and dental offices, emergency medical services, long-term care, schools and a variety of other healthcare facilities. Professional Disposables International, Inc. is headquartered in Orangeburg, New York. For more information visit http://www.pdipdi.com.

Since 1902, HIDA, the trade association representing medical products distributors, has provided leadership in healthcare distribution.

(1) June 30, 2009 (http://www.cdc.gov/h1n1flu/qa.htm) Image Courtesy of CDC/ C. S. Goldsmith and A. Balish. Sani-Hands® is a registered trademark of Professional Disposables International, Inc. © 2009 Professional Disposables International, Inc. ISO 9001:2008 Certified

(2) Label Guidance for Antimicrobial Pesticides Used Against Avian Influenza A, March 8, 2007, p. 2 & EPA’s Antimicrobial Products Registered for Use Against the H1N1 Flu and Other Influenza A Viruses on Hard Surface, May 13, 2009, p. 1.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Related Influenza Press Releases

Laredo, TX and Austin, TX (PRWEB) August 26, 2009

The City of Laredo Health Department (CLHD) and the Laredo Independent School District (LISD) are installing a “first-in-the nation,” Internet-based system for early identification of possible novel Influenza H1N1 virus infection of students, teachers and staff. The virus is commonly known as the “swine flu.”

The system, known as Argus1, also provides decision support for school nurses and other providers in caring for sick students; instant alerts such as vaccine recommendations, and continuous reporting and tracking of outbreaks to the CLHD and school authorities.

“In addition to Influenza A H1N1, the system also provides point-of-contact surveillance for other forms of influenza as well as the potential to track other public health infectious diseases and chemical agents that the U.S. Dept. of Homeland Security has identified as possible agents in a biological or chemical terrorist attack,” said Robert Burns, Director of Information Technology for Argus One Systems, Inc.

Argus1 was introduced in Laredo as part of a test site from 2003 to 2006. Its re-deployment for the 2009-10 school year is based on extensive testing and refinement of the system, with particular attention to the new Influenza A H1N1 virus. Argus1 also can be used by physician offices, emergency medical responders and hospital emergency departments, Burns noted.

Patricia Keck, Director of LISD Health Services, stated:

“Argus 1 will be an important part of our ‘Fight the Flu’ program. By quickly receiving reports from school nurses, LISD Health Services Department in conjunction with the City of Laredo is able to track illness patterns. If an illness pattern develops at an LISD school, we will provide the school with intensified flu prevention recommendations. Argus1 is a valuable weapon in fighting flu outbreaks.”

“In addition to assisting nurses caring for sick students, Argus1 provides a distinctive reporting function to the CLHD, which has played a key role in the design and development of the system during the past six years,” said Vincent Friedewald, MD, Medical Director of Argus One Systems.

“This surveillance system is an important adjunct to track and monitor disease from the onset at the provider level and to quickly report to the CLHD for a rapid response intervention to contain disease,” said Hector Gonzalez, MD, MPH, Director of the city’s Health Dept.

“The system is secured and uses both landline and wireless Internet-connected computers,” explained Friedewald, a Clinical Professor of Medicine at the University of Texas Health Science Center – Houston.

Argus1 assesses signs, symptoms, test results

“An important part of the program involves assessment of patients’ signs, symptoms and test results, which are instantly transformed into a comprehensive list of possible disease causes and detailed information about each of the diseases,” he added.

Additionally, when a person’s symptoms match any of nine categories of public health syndromes, including influenza-like illnesses, the exact time and location is reported to both the CLHD and to the central office of the School District, he said. All reported cases are instantly displayed on a map of the City of Laredo so that potential cases are immediately tracked to help officials decide how to prevent its spread throughout the schools and the community at large.

“As the school year begins, we are entering a potentially very dangerous period with a new influenza virus that particularly affects young persons,” emphasized Friedewald, who is an Associate Editor for The American Journal of Cardiology, as well as a research professor in the College of Science at the University of Notre Dame

“Our ability to build on our existing relationship with the LISD and the CLHD should afford the children, as well as the entire community of Laredo, a proven and unsurpassed level of added protection” he said.

Argus One Systems, Inc., is headquartered in Rosenberg, TX (near Houston), with editorial offices in Austin, TX and technology offices in Memphis, TN.

FOR MORE INFORMATION OR INTERVIEWS:

Preston F. Kirk, APR, Kirk Public Relations, Austin TX, 830-693-4447; cell, 512-940-4402

Vincent Friedewald, MD, Argus One Systems, Inc., Austin TX

Mr. Robert Burns, Director of Information Technology, Argus One Systems, Inc., Rosenberg, TX

Patricia C. Keck, MSN, RN, Director of Health Services, Laredo I.S.D., Laredo, TX, 956-795-4160

###

Attachments

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Related Influenza Press Releases

(PRWEB) November 2, 2005

An innovative new water treatment system could provide the UK’s poultry farmers with an extra line of defence against the spread of avian influenza in the national flock.

The Aqualution system, developed by UK company Forum Bioscience, was originally developed to help producers reduce the incidence of food poisoning bacteria such as Campylobacter and Salmonella. But during regulatory tests required under the EU’s Biocidal Products Directive, the system demonstrated its ability to destroy the avian influenza virus where it’s present in drinking water – believed to be a possible means of transmission between birds.

“The Food Standards Agency (FSA) says Campylobacter is the single biggest cause of food-borne illness in the United Kingdom,” explains Tom Ritchie, business manager with Forum Bioscience, “so Aqualution satisfied the demand from producers for a product which could be used successfully during production.

“But the speed with which avian influenza has moved across Asia and into Europe has forced producers to consider contingency plans for their flocks, should the disease become commonplace among birds in the UK,” he points out.

“Several producers have expressed an interest in installing Aqualution as their extra line of defence. It provides them with an alternative to conventional chemicals such as chlorine or ozone, where the concentrations required can often have a harmful effect on the birds. Such treatments are also unpopular with consumers who, understandably, are becoming more ‘savvy’ about the methods employed to produce their food.

“Aqualution relies on electrolysis to generate ‘activated water’, containing a very small amount of chlorine (3-5ppm) and high concentrations of dissolved oxygen. The combination is terrifically effective against pathogens,” he stresses.

On a typical unit, drinking water will often contain pathogen counts of 100,000/ml. Once Aqualution has been installed, this reduces to 10/ml and often zero.

“Because the water stays ‘active’ up to the point of drinking, the system helps prevent spread of disease between birds,” Mr Ritchie explains. “In addition, we have fogging trials underway to look at the effectiveness of the system for controlling airborne transmissions. If successful, this could then be used inside sheds and control rooms, as well as at farm entrances for disinfecting vehicles.”

Independent testing has shown that the treated water satisfies the British Disinfectant Standard against a range of problem pathogens including Pseudomonas, E.coli and Campylobacter, as well as avian influenza and a number of other viruses.

The system can also boost end profits and animal welfare. “Extensive trial results show that for meat production, a combination of reduced bird mortality, increased growth rates and better food conversion are achieved. In layers and breeders there is also greater egg and chick yield, and litter is drier – easing consumer concerns about ‘hock burn’.”

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Related Influenza Press Releases

Ft. Collins, CO (PRWEB) August 16, 2006

Better Process Podcast (voice of the small and mid-sized manufacturing firm) releases a three part series on pandemic influenza planning for businesses with Chris Spence – President of Future Health Solutions. Future Health Solutions works with wide variety of companies for pandemic influenza planning, preparation and business continuity planning.

Mr. Spence presents frequently to public health and business groups on pandemic influenza. These presentations are typically 1 to 2 hours. The three 5 minute podcasts have attempted to introduce each of the following topics:

Podcast 1: Science and history of pandemics (release 8-14)

Podcast 2: Current situation and government planning efforts (release 8-15)

Podcast 3: Business impact and business continuity planning. (release 8-16)

“We are pleased to have such a knowledgeable guest about this topic on our show,” says Ken Rayment podcaster for the Better Process Podcast on PodcasterNews.com. “Although Chris is very typical of the person we interview – very specific and detailed information in their topic area; we typically do not hear from the health industry in our manufacturing focused podcast.”

The first show in the 3 part series can be found at:

http://www.podcasternews.com/programs/87/better-process-podcast/2431/

All three shows have a permanent link and will remain on the PodcasterNews.com site. Links to these shows will not break in the future.

About Better Process Podcast

Based in Colorado and across the US via Skype, the Better Process Podcast interviews small and mid-sized manufacturing companies, and the companies that service these companies. Shows are free to download from iTunes (search for Better Process Podcast in iTunes music store) and are available most business days. More information on the show can be found at http://www.BetterProcess.com. The Better Process Podcast is the voice of the small and mid-sized manufacturing firm.

About Future Health Solutions

Future Health Solutions works with wide variety of companies for pandemic influenza planning, preparation and business continuity planning. To see or hear more on this topic or to discuss how Future Health Solutions can help your company prepare for pandemic flu, contact Chris at (860) 368-2435.

About PodcasterNews.com

PodcasterNews hosts short podcasts up to 5 Minutes in length produced by our network of content producers. It is a place to listen to your own news selections in 3 easy steps. 1. Create a free PCN account 2. Choose the shows that interest you 3. Listen to your show: Listen on the site using MyCast or add your custom RSS feed to your favorite podcatcher. Your feed will stay updated with new content. As you add or remove shows your MyCast list and your custom RSS feed stays updated.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

More Influenza Press Releases

Boston, MA (PRWEB) April 7, 2008

Replikins, Ltd. has found that the Replikin Count™ of the H1N1 strain of influenza virus has recently increased to 7.6 (plus/minus 1.4), its highest level since the 1918 H1N1 pandemic (p value less than 0.001). A rising Replikin Count of a particular influenza strain, indicating rapid replication of the virus, is an early warning which has been followed consistently by an outbreak of the specific strain. The current increase appears to be specific to H1N1; there was a concurrent 80% decline in the Replikin Count of H3N2, for instance.

The current H1N1 appears to be rapidly replicating simultaneously in the U.S. and Austria. It may succeed H5N1 as the leading candidate for the next expected overdue pandemic. However, the same virus replikin structures detected by FluForecast® software in all three previous pandemics, namely 1918 H1N1, 1957 H2N2, and 1968 H3N2, as well as in H5N1, have not yet been detected in the currently evolving H1N1.

There is evidence that many factors, including virus structure, host receptivity, and the environment, together with infectivity and rapid replication, need to converge for a pandemic to occur. For H5N1, the high human mortality rate, which peaked at over 80% in 2006-07 in Indonesia, as well as current low infectivity, both appear to limit H5N1′s ability to produce a pandemic. Furthermore, the H5N1 rapid replication cycle which began in 1996 now appears to be over. The H5N1 virus produced less than 300 World Health Organization confirmed deaths over the past 10 years.

On the other hand, H1N1, with an estimated human mortality rate of only 2.5 to 10%, but with much higher infectivity, produced an estimated 50 million deaths in the 1918 pandemic. A number of countermeasures exist today which did not exist in 1918, however. Among these is Replikins’ ability to manufacture synthetic vaccines based on current sequences, with a seven day production turnaround.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Find More Influenza Press Releases

(PRWEB) March 16, 2005

There are no new vaccines being mass produced by any country in response to the projected Asian epidemic of bird flu, despite calls from the World Health Organization (WHO) for countries to stockpile vaccines before it’s too late.

In response to the startling new Who projections, natural health author Mike Adams has released a report listing the Top 12 antiviral herbs and nutrients for beating the bird flu virus, available for download now from Truth Publishing at http://www.truthpublishing.com

The new report, “Beat the Bird Flu Virus,” provides a quick reference list of the best antiviral herbs available for boosting immunity. This previously unreleased list of the Top 12 foods, nutrients and herbs that stave off infection is resourced from books and research authored by over 15 doctors and nutrition professionals.

The top antiviral foods and nutrients named in the list include elderberry extract, zinc, St. John’s Wort and Astragalus herbs.

If the bird flu virus strikes, vaccines will be in short supply because no nations are making any vaccine yet,” said Mike Adams, nutritionist and “Beat the Bird Flu Virus” author. “The best alternative source for increasing your protection is to use the 12 herbs and nutrients named in this report,” he said.

To get the latest situation updates on avian influenza or H5N1 bird flu virus from Who, visit http://www.who.int/csr/disease/avian_influenza/en/

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Related Influenza Press Releases